This group is interested in defining the
cellular and molecular mediators associated with liver regeneration under conditions associated with restitution to integrum and in conditions associated with extracellular
matrix deposition, with the final goal to design new pharmacological approaches able to increase liver regeneration in patients suffering of acute or chronic hepatic insufficiency.